공시 • Nov 22
bleuacacia to Redeem All of the Outstanding Ordinary Shares, Effective November 22, 2024 and to File Form 15 with the SEC to Terminate the Registration of its Securities bleuacacia ltd (the ‘Company’) announced that, due to its inability to complete an initial business combination within the time period required by its amended and restated memorandum and articles of association, as amended, the Company intends to liquidate and dissolve, effective as of the close of business on November 22, 2024, and will redeem all of the outstanding ordinary shares that were included in the units issued to public shareholders in its initial public offering (the ‘Public Shares’), at a per-share redemption price of approximately $11.10 (after the removal of a portion of the accrued interest in the trust account to pay taxes and up to $100,000 of dissolution expense). As of the close of business on November 22, 2024, the Public Shares will be deemed cancelled and will represent only the right to receive the redemption amount. In order to provide for the disbursement of funds from the trust account, the Company will instruct the trustee of the trust account to take all necessary actions to liquidate the trust account. The proceeds of the trust account will be held in a non-interest bearing account while awaiting disbursement to the holders of the Public Shares. Record holders will receive their pro rata portion of the proceeds of the trust account by delivering their Public Shares to Continental Stock Transfer & Trust Company, the Company’s transfer agent. Beneficial owners of Public Shares held in ‘street name,’ however, will not need to take any action in order to receive the redemption amount. The redemption of the Public Shares is expected to be completed within ten business days after November 22, 2024. The Company’s holders of founder shares have agreed to waive their redemption rights with respect to such shares. There will be no redemption rights or liquidating distributions with respect to the Company’s warrants and rights, which will expire worthless. The Company expects to file a Form 15 with the United States Securities and Exchange Commission (the ‘SEC’) to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended, within ten days of the filing of a Form 25. 공시 • Sep 12
bleuacacia Receives Notice of Deficiency from Nasdaq bleuacacia ltd announced that on September 6, 2024, it received a notice (the Notice) from the Listing Qualifications department of The Nasdaq Stock Market LLC that the Company no longer complies with Nasdaq Listing Rule 5250(c)(1), which requires companies with securities listed on Nasdaq to timely file all required periodic reports with the U.S. Securities and Exchange Commission (the SEC). As previously disclosed in the Notification of Late Filing on Form 12b-25 filed by the Company with the SEC on August 15, 2024 (the Form 12b-25), the Company is delayed in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the Form 10-Q) due to the reasons described in the Form 12b-25. The Notice has no immediate effect on the listing or trading of the Company's common stock on Nasdaq. The Company has 60 calendar days, or until November 5, 2024, to submit a plan to regain compliance with the Listing Rule (the Plan). Pursuant to the Notice, if Nasdaq accepts the Plan, Nasdaq can grant the Company an exception of up to 180 calendar days from the due date of the Form 10-Q, or until February 17, 2025, to regain compliance with the Listing Rule. There can be no assurance that the Company will be able to regain compliance within the applicable time period. In addition, if the Company does not regain compliance within the applicable time period, Nasdaq could provide a notice that the Company's securities will become subject to delisting. If the Company receives such delisting notice, Nasdaq rules permit the Company to appeal the decision to a hearings panel. 공시 • Aug 16
bleuacacia ltd announced delayed 10-Q filing On 08/15/2024, bleuacacia ltd announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • May 17
bleuacacia ltd announced delayed 10-Q filing On 05/15/2024, bleuacacia ltd announced that they will be unable to file their next 10-Q by the deadline required by the SEC. 공시 • Apr 02
bleuacacia ltd announced delayed annual 10-K filing On 04/01/2024, bleuacacia ltd announced that they will be unable to file their next 10-K by the deadline required by the SEC. 공시 • Jan 12
bleuacacia to Transfer the Listing of Its Securities from the Nasdaq Global Market to the Nasdaq Capital Market On January 8, 2024, bleuacacia ltd (the “Company”) received notice from the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) approving the Company’s application to transfer the listing of its securities from The Nasdaq Global Market to The Nasdaq Capital Market. The Company’s securities will be transferred to The Nasdaq Capital Market at the open of business on January 11, 2024. The Company’s securities—i.e., its common stock, units, rights and warrants—will continue to trade under the symbols “BLEU,” “BLEUU,” “BLEUR” and “BLEUW,” respectively, which trading will be unaffected by the transfer. The Nasdaq Capital Market operates in substantially the same manner as the Nasdaq Global Market. As previously disclosed in the Current Report on Form 8-K filed with the SEC on July 10, 2023, the Company had received written notice dated July 5, 2023 from the Staff that it was not then in compliance with a continued listing requirement of the Nasdaq Global Market to maintain a minimum Market Value of Listed Securities as set in Nasdaq Listing Rule 5450(b)(2)(A). Upon the transfer of the listing of the Company’s securities to the Nasdaq Capital Market, however, this deficiency will be resolved because the Company will no longer be subject to the continued listing requirements for The Nasdaq Global Market. 공시 • Jan 07
Bleuacacia Provides Non-Compliance Update As previously disclosed in the Current Report on Form 8-K filed with the SEC on July 10, 2023 (the “Initial Deficiency 8-K”), bleuacacia ltd had received written notice dated July 5, 2023 from the Listing Qualifications department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that it was not then in compliance with a continued listing requirement to maintain a minimum Market Value of Listed Securities of $50,000,000, as set in Nasdaq Listing Rule 5450(b)(2)(A) and, subject to the Staff’s determination of the Company’s ability to cure such deficiency—either by regaining compliance or by transferring its listed securities to the Nasdaq Capital Market (the “Capital Market”)—within the 180 calendar day compliance period as set in Nasdaq Listing Rule 5810(c)(3)(C), its listed securities may be subject to delisting following receipt of an additional written notice to such effect issued by the Staff, appealable by the Company to Nasdaq’s Hearings Panel. The 180 calendar day compliance period expired on January 2, 2024. As of the date hereof, however, the Company is not in receipt of such additional written notice and continues to consider its available options to cure the deficiency, including measures in furtherance of demonstrating its capacity to satisfy the requirements necessary to timely transfer its listed securities to the Capital Market. Although the expiration of the 180 calendar day compliance period has no immediate effect on the listing or trading of the Company’s Class A ordinary shares, which continue to trade on The Nasdaq Global Market under the symbol “BLEU,” there can be no assurance that the Company will be able to regain compliance with applicable listing requirements in order to maintain its current listing or satisfy the requirements necessary to timely transfer its listed securities to the Capital Market. Board Change • Dec 08
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Kat Peeler was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Oct 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Kat Peeler was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. New Risk • Aug 17
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: US$88.4m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Shares are highly illiquid. Negative equity (-US$10m). Revenue is less than US$1m. Minor Risks Less than 3 years of financial data is available. Market cap is less than US$100m (US$88.4m market cap). Board Change • Aug 15
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Kat Peeler was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 공시 • Jul 12
bleuacacia Receives Written Notice from Nasdaq Regarding Minimum Market Value of Listed Securities On July 5, 2023, bleuacacia ltd (the Company") received written notice from the Listing Qualifications department (the Staff") of The Nasdaq Stock Market LLC (Nasdaq") that the Company was not in compliance with the continued listing requirement to maintain a minimum Market Value of Listed Securities (MVLS") of $50,000,000, as set in Nasdaq Listing Rule 5450(b)(2)(A). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has a period of 180 calendar days, or until January 2, 2024, to regain compliance with the minimum MVLS requirement. To regain compliance, the Company's MVLS must close at $50,000,000 or more for a minimum of ten consecutive business days during this 180 calendar day compliance period. In the event that the Company does not regain compliance within the 180 calendar day compliance period, the Company may be eligible to transfer to the Nasdaq Capital Market (the Capital Market") prior to the expiry of this period, provided that it satisfies the requirements for continued listing on the Capital Market. There can be no assurance that the Company will be able to regain compliance with Nasdaq Listing Rule 5450(b)(2)(A), or maintain compliance with any other listing requirements to maintain its current listing on the Nasdaq Global Market or satisfy the requirements necessary to transfer the listing of its ordinary shares to the Capital Market. The MVLS notice is a notification of deficiency, not of delisting, and has no immediate effect on the listing of the Company's securities on Nasdaq. If it appears to the Staff that the Company will not be able to cure the deficiency prior to January 2, 2024, the Staff will provide written notice to the Company that its listed securities will be subject to delisting. In the event of such notification, the Company may appeal the Staff's determination to delist its securities, but there can be no assurance Nasdaq would grant the Company's request for continued listing. The Company intends to consider its available options to resolve the Company's noncompliance with Nasdaq Listing Rule 5450(b)(2)(A). 공시 • May 16
bleuacacia ltd announced delayed 10-Q filing On 05/15/2023, bleuacacia ltd announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Kat Peeler was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 공시 • Nov 11
bleuacacia ltd Appoints Kat Peeler as A Director and A Member of the Audit Committee On November 4, 2022, the board of directors of bleuacacia ltd appointed Kat Peeler as a director and a member of the audit committee effective as of November 4, 2022. The board has determined that Ms. Peeler is an independent director. Ms. Peeler will serve as a director of the company with a term of office that shall extend until the next annual meeting of shareholders of the Company or, if earlier, the date of her resignation or removal from the Board. Since September 2016, Ms. Peeler has served as the Chief Executive Officer of Eco Guar Group, a global value added B2B supplier of non-GMO Guar products with a focus on sustainability and ethical community fair trade. Prior to this, Ms. Peeler was a senior executive at L’Oreal, the beauty products company, from 1998 to 2015. Her roles included Senior Vice-President of Garnier consumer business. Ms. Peeler received a Bachelor of Science in Engineering (BSE) degree from Princeton University and a Master of Management (MM) degree from Kellogg School of Management, Northwestern University. On November 4, 2022, in connection with Ms. Peeler’s appointment to the Board, the Company and Ms. Peeler entered into (i) a joinder to the letter agreement dated November 17, 2021, entered into by and among the Company, its officers, directors and senior advisors at the time of the Company’s initial public offering and bleuacacia sponsor LLC, which was filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 22, 2021 (the “Current Report”), (ii) a joinder to the registration rights agreement entered into by and among the Company, the Sponsor and the holders party thereto, which was filed as Exhibit 10.3 to the Current Report, under which Ms. Peeler will be granted certain registration rights on the same terms as the other holders at the time of the Company’s initial public offering and (iii) an indemnity agreement (on the same terms as the indemnity agreements entered into by the directors and officers of the Company at the time of the company’s initial public offering, a form of which was filed as Exhibit 10.6 to the Current Report. Board Change • Jul 01
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Ibukun Awosika was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 공시 • Apr 03
bleuacacia ltd announced delayed annual 10-K filing On 04/01/2022, bleuacacia ltd announced that they will be unable to file their next 10-K by the deadline required by the SEC. Board Change • Jan 12
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Ibukun Awosika was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 